Target Details
| UniProt AC | P42345 |
|---|---|
| Gene Symbol | MTOR |
| Protein Name | Serine/threonine-protein kinase mTOR |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF02259 (FAT) PF02260 (FATC) PF08771 (FRB_dom) PF23593 (HEAT_ATR) PF11865 (mTOR_dom) PF00454 (PI3_PI4_kinase) |
Summary
- Multi-target molecules 2,517
- Clinical molecules 193
- Avg pChEMBL 7.75
KEGG Pathways (53)
- AMPK signaling pathway
- Acute myeloid leukemia
- Adipocytokine signaling pathway
- Alzheimer disease
- Amyotrophic lateral sclerosis
- Apelin signaling pathway
- Autophagy - animal
- Autophagy - other
- Breast cancer
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Colorectal cancer
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- ErbB signaling pathway
- Gastric cancer
- Glioma
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Huntington disease
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Lysosome biogenesis
- MicroRNAs in cancer
- Neutrophil extracellular trap formation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Shigellosis
- Spinocerebellar ataxia
- Th17 cell differentiation
- Thermogenesis
- Thyroid hormone signaling pathway
- Type II diabetes mellitus
- mTOR signaling pathway
Associated Diseases (2)
Active Molecules (2,517)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
VQCWJZWGHDLXCC
|
8.9 | IC50 | 3 | — | |
BRAHJBBKMUUXMR
|
8.9 | IC50 | 2 | — | |
GBHIWMONUYHJTE
|
8.9 | IC50 | 2 | — | |
JFMAOEQGINOHKN
|
8.9 | Ki | 2 | — | |
FVOXAVYMKTXHTN
|
8.9 | IC50 | 3 | — | |
LWSJQJQMKYBWTR
|
8.9 | IC50 | 3 | — | |
PDNHZNUDWLUQQC
|
8.9 | IC50 | 2 | — | |
QEZCXGHWXXLBFJ
|
8.9 | IC50 | 2 | — | |
RJGLKNSJUHURHU
|
8.9 | IC50 | 2 | — | |
SEBHGEYNGDJWAR
|
8.9 | IC50 | 3 | — | |
XAANLSVGMMQAAB
|
8.9 | IC50 | 3 | — | |
YPXRCUVTZDXVHY
|
8.9 | IC50 | 7 | — | |
GCCIALHRRNPWDW
|
8.9 | IC50 | 2 | — | |
OKGVTZIBZSTGQP
|
8.9 | IC50 | 2 | — | |
CXSYPIORXDVQHI
|
8.9 | IC50 | 2 | — | |
QDOGZMBPRITPMZ
|
8.9 | IC50 | 3 | — | |
RCBPKJSWTWFJMU
|
8.9 | IC50 | 3 | — | |
STDZGEQBCPCVMV
|
8.9 | IC50 | 2 | — | |
VROHDVQPMGULKN
|
8.9 | IC50 | 2 | — | |
ABEZBUPUYCZAAU
|
8.9 | IC50 | 3 | — | |
CTDQVLXGZGAQRL
|
8.9 | IC50 | 2 | — | |
FAJLRTZRULGGMR
|
8.9 | IC50 | 2 | — | |
NVVYGAOHSAGFRS
|
8.9 | IC50 | 2 | — | |
WPVJZZMEAKIEQW
|
8.9 | IC50 | 2 | — | |
XJPHXYLUBXRUNF
|
8.9 | IC50 | 3 | — | |
APYPCVRCUBVUDW
|
8.9 | IC50 | 2 | — | |
IPQHUWHABHOECT
|
8.9 | IC50 | 2 | — | |
YISUJHWAXSJJDA
|
8.9 | IC50 | 2 | — | |
IPZAMJYKUJQWJY
|
8.9 | IC50 | 2 | — | |
JAXNYWPAXUSWOH
|
8.9 | IC50 | 2 | — | |
MRUIWDOXCOAESS
|
8.9 | IC50 | 2 | — | |
YWKQALJDAFOFGE
|
8.9 | Ki | 2 | — | |
BCTJBMRLXUOXJQ
|
8.8 | IC50 | 3 | — | |
CFYIBWFGBQGKRX
|
8.8 | IC50 | 2 | — | |
FAUUWGBRPQXEOZ
|
8.8 | Ki | 3 | — | |
GACQNUHFDBEIQH
|
8.8 | Ki | 4 | — | |
GVOIDFSKGKJIQS
|
8.8 | IC50 | 2 | — | |
GYLDXIAOMVERTK
|
8.8 | IC50 | 9 | — | |
KWSSUPFLCWAJAS
|
8.8 | IC50 | 2 | — | |
MDOHUUXUSJCWPN
|
8.8 | IC50 | 2 | — | |
QOPDQIJAEIICJK
|
8.8 | IC50 | 2 | — | |
QXOKIFGIUZOQBL
|
8.8 | IC50 | 2 | — | |
XDXZHIQVJAQRGY
|
8.8 | IC50 | 2 | — | |
XUYPPKAYBHIWJO
|
8.8 | IC50 | 2 | — | |
YXFAAQVTSYIBFS
|
8.8 | Ki | 2 | — | |
ZDJOKGUTKMZKCX
|
8.8 | IC50 | 3 | — | |
CPPLHJFZALNRGR
|
8.8 | IC50 | 2 | — | |
DTPFVQJDLZXQAV
|
8.8 | Ki | 2 | — | |
DCXXMIPGVUHHCP
|
8.8 | IC50 | 2 | — | |
ROJIUPHRPUXJBN
|
8.8 | IC50 | 2 | — |